- Home
- WWD vs ITCI Comparison
WWD vs ITCI Comparison
Compare WWD & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WWD
- ITCI
- Stock Information
- Founded
- WWD 1870
- ITCI 2002
- Country
- WWD United States
- ITCI United States
- Employees
- WWD N/A
- ITCI N/A
- Industry
- WWD Industrial Machinery/Components
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- WWD Energy
- ITCI Health Care
- Exchange
- WWD Nasdaq
- ITCI Nasdaq
- Market Cap
- WWD 9.7B
- ITCI 8.0B
- IPO Year
- WWD N/A
- ITCI N/A
- Fundamental
- Price
- WWD $164.32
- ITCI $75.03
- Analyst Decision
- WWD Buy
- ITCI Strong Buy
- Analyst Count
- WWD 9
- ITCI 11
- Target Price
- WWD $180.75
- ITCI $97.00
- AVG Volume (30 Days)
- WWD 403.9K
- ITCI 458.3K
- Earning Date
- WWD 07-29-2024
- ITCI 10-31-2024
- Dividend Yield
- WWD 0.61%
- ITCI N/A
- EPS Growth
- WWD 80.33
- ITCI N/A
- EPS
- WWD 5.98
- ITCI N/A
- Revenue
- WWD $3,246,831,000.00
- ITCI $564,526,000.00
- Revenue This Year
- WWD $13.77
- ITCI $46.60
- Revenue Next Year
- WWD $4.22
- ITCI $37.06
- P/E Ratio
- WWD $27.33
- ITCI N/A
- Revenue Growth
- WWD 16.90
- ITCI 54.31
- 52 Week Low
- WWD $119.03
- ITCI $45.50
- 52 Week High
- WWD $188.35
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- WWD 48.86
- ITCI 52.68
- Support Level
- WWD $161.06
- ITCI $73.05
- Resistance Level
- WWD $168.00
- ITCI $76.98
- Average True Range (ATR)
- WWD 3.95
- ITCI 1.82
- MACD
- WWD 0.40
- ITCI 0.27
- Stochastic Oscillator
- WWD 41.44
- ITCI 62.72
About WWD Woodward Inc.
Woodward Inc is an independent designer, manufacturer, and service provider of control solutions for the aerospace and industrial markets. It designs, produces, and service reliable, efficient, low-emission, and high-performance energy control products for diverse applications in challenging environments. The company holds production and assembly facilities primarily in the United States, Europe, and Asia, and promotes products and services through worldwide locations.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.